Observational Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Feb 16, 2023; 11(5): 1049-1057
Published online Feb 16, 2023. doi: 10.12998/wjcc.v11.i5.1049
Table 1 Demographics and characteristics of the patients
Parameter
Value
Agea in yr68 (r34-74)
Male/female5 (45.5)/6 (54.5)
BMI18 (r14.3-23)
ASAI/II/III/IV2 (18.2)/9 (81.8)/0/0
ECOG 0/1/2/3/43 (27.3)/8 (72.7)/0/0/0
CEA > 5 ng/mL10 (90.9)
Tumor sizea in mm65 (r50-90)
Neoadjuvant chemotherapy0
TN classification
T4bN06 (54.5)
T4bN13 (27.3)
T4bN22 (18.2)
Table 2 Perioperative and postoperative results
Parameter
Value
Operative timea in min241.36 ± 31.23
Blood lossa in mL190.91 ± 59.07
Perioperative complications by Clavien-Dindo classification3 (27.3)
I2 (18.2) incision infection
II1 (9.1) lymphatic leak
III0
IV0
V0
Time to first bowel movementa3.45 ± 1.04
Time to resumption of regular dieta7.55 ± 1.21
Hospital staya18.09 ± 4.21
30-d mortality0
30-d readmission1 (9.1)
Table 3 Short-and medium-term outcomes
ParameterValue
Follow-upa in mo41 (r7-58)
Adjuvant chemotherapy5 (45.5)
Completed chemotherapy4 (36.4)
Recurrence3 (27.3)
Time to recurrencea in mo32 (r6-36)
Recurrence sites
Lymph node1 (9.1)
Liver1 (9.1)
Peritoneum1 (9.1)
Disease-free survival
1-yr90.9%
2-yr90.9%
3-yr75.8%
Overall survival
1-yr90.9%
2-yr90.9%
3-yr90.9%
Deaths2 (18.2)